Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

Achieving Optimal Medical Therapy: Insights From the ORBITA Trial

Background In stable coronary artery disease, medications are used for 2 purposes: cardiovascular risk reduction and symptom improvement. In clinical trials and clinical practice, medication use is often not optimal. The ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therapy...

全面介绍

书目详细资料
Main Authors: Michael Foley, Christopher A. Rajkumar, Matthew Shun‐Shin, Sashiananthan Ganesananthan, Henry Seligman, James Howard, Alexandra N. Nowbar, Thomas R. Keeble, John R. Davies, Kare H. Tang, Robert Gerber, Peter O’Kane, Andrew S. P. Sharp, Ricardo Petraco, Iqbal S. Malik, Sukhjinder Nijjer, Sayan Sen, Darrel P. Francis, Rasha Al‐Lamee
格式: 文件
语言:English
出版: Wiley 2021-02-01
丛编:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主题:
adverse effects
angina
compliance/adherence
medical therapy
randomized controlled trial
在线阅读:https://www.ahajournals.org/doi/10.1161/JAHA.120.017381

因特网

https://www.ahajournals.org/doi/10.1161/JAHA.120.017381

相似书籍